Kimberly Leach, DPM
Podiatrist · Mesa, AZNPI 1538139449
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Abbott at 37.3% of the total. Reporting peaked in 2022 at $501 and has fallen 86.1% since, to $70 in 2025.
Across 101 payments — averaging $11.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$452
- Angiodynamics, Inc.$257
- Stryker$102
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$69
- Orthofix Medical, Inc.$62
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$55
- plus $213 from 10 others
What the payments were for
- Food & beverage$1,209100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 46 | $452 |
| Angiodynamics, Inc. | 25 | $257 |
| Stryker(2 entities) | 3 | $102 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $69 |
| Orthofix Medical, Inc. | 6 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $55 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Smith+Nephew | 2 | $29 |
| Advanced Oxygen Therapy Inc. | 2 | $28 |
| Nevro Corp. | 1 | $27 |
| Edwards Lifesciences | 1 | $19 |
| Amgen | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $15 |
| Fusion Orthopedics USA, LLC | 1 | $11 |
How this compares
$1,209 in reported general payments places this provider in the 60th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 88 | $2,498 |
| Pregabalin | 21 | $571 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $444 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $441 |
| Methylprednisolone | 28 | $202 |
| Doxycycline Hyclate | 19 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $153 |
| Mupirocin | 12 | $150 |
| Gabapentin | 12 | $99 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $97 |
| Celecoxib | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Mesa
- Lewis FreedMesa$997K
- Kerry ZangMesa$111K
- Todd HaddonMesa$94K
- Spencer HardyMesa$4K
- Douglas GriffinMesa$2K
- Kris DinucciScottsdale$1.4M
- Stephen KominskySun City West$508K
- Chad WestphalPeoria$300K
- Paul BishopScottsdale$87K
- Barbara AungTucson$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.